Isolated Systolic Hypertension in Young People Is Not Spurious and Should Be Treated

DOI Web Site 1 Citations

Carmel M. McEniery

From the Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK (C.M.M., I.B.W.); Heart Disease Prevention Program, University of California, Irvine (S.S.F.); and Cardiff School of Health Sciences, Cardiff Metropolitan University, Cardiff, United Kingdom (J.R.C.).
Stanley S. Franklin

From the Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK (C.M.M., I.B.W.); Heart Disease Prevention Program, University of California, Irvine (S.S.F.); and Cardiff School of Health Sciences, Cardiff Metropolitan University, Cardiff, United Kingdom (J.R.C.).
John R. Cockcroft

From the Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK (C.M.M., I.B.W.); Heart Disease Prevention Program, University of California, Irvine (S.S.F.); and Cardiff School of Health Sciences, Cardiff Metropolitan University, Cardiff, United Kingdom (J.R.C.).
Ian B. Wilkinson

From the Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK (C.M.M., I.B.W.); Heart Disease Prevention Program, University of California, Irvine (S.S.F.); and Cardiff School of Health Sciences, Cardiff Metropolitan University, Cardiff, United Kingdom (J.R.C.).

Bibliographic Information

Other Title

Hypertension

Hypertension 68 (2), 269-275, 2016-08

Ovid Technologies (Wolters Kluwer Health)

Back to top